Susquehanna International Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $313K | Sell |
|
|||||
|
2025
Q2 | $497K | Buy |
|
|||||
|
2025
Q1 | $107K | Buy |
|
|||||
|
2024
Q4 | $31.8K | Buy |
|
|||||
|
2024
Q3 | $9.96K | Sell |
|
|||||
|
2024
Q2 | $71.1K | Buy |
|
|||||
|
2024
Q1 | $52.3K | Sell |
|
|||||
|
2023
Q4 | $66.6K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $58.1K | Sell |
|
|||||
|
2023
Q1 | $1.22M | Buy |
|
|||||
|
2022
Q4 | $203K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $163K | Sell |
|
|||||
|
2021
Q3 | $302K | Buy |
|
|||||
|
2021
Q2 | $207K | Sell |
|
|||||
|
2021
Q1 | $2.35M | Buy |
|
|||||
|
2020
Q4 | $240K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $25K | Sell |
|
|||||
|
2019
Q4 | $53K | Sell |
|
|||||
|
2019
Q3 | $65K | Sell |
|
|||||
|
2019
Q2 | $121K | Buy |
|
|||||
|
2019
Q1 | $95K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $63K | Buy |
|
|||||
|
2018
Q1 | $72K | Sell |
|
|||||
|
2017
Q4 | $185K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $116K | Sell |
|
|||||
|
2017
Q1 | $159K | Sell |
|
|||||
|
2016
Q4 | $464K | Buy |
|
|||||
|
2016
Q3 | $96K | Buy |
|
|||||
|
2016
Q2 | $40K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $155K | Buy |
|
|||||
|
2015
Q2 | $106K | Sell |
|
|||||
|
2015
Q1 | $213K | Buy |
|
|||||
|
2014
Q4 | $96K | Sell |
|
|||||
|
2014
Q3 | $109K | Sell |
|
|||||
|
2014
Q2 | $141K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $43K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $142K | Buy |
|